SCHEMBL4026317

SCHEMBL4026317

NCCCn1c2c(c3cc(Br)ccc31)CCCC2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCARB1 Q8WTV0 10/20 0.46
KRAS P01116 2/20 0.45
HTR6 P50406 3/20 0.45
HRH1 P35367 2/20 0.45
CHRM2 P08172 1/20 0.45
HTR1A P08908 1/20 0.45
CHRM5 P08912 1/20 0.45
ADRA2A P08913 1/20 0.45
DRD2 P14416 1/20 0.45
ADRA2B P18089 1/20 0.45
ADRA2C P18825 1/20 0.45
CHRM3 P20309 1/20 0.45
DRD4 P21917 1/20 0.45
SLC6A2 P23975 1/20 0.45
HRH2 P25021 1/20 0.45
HTR2A P28223 1/20 0.45
HTR2C P28335 1/20 0.45
AVPR2 P30518 1/20 0.45
ADRA1A P35348 1/20 0.45
DRD3 P35462 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4193417 0.86 SCARB1 (0.46) SCARB1KRASHTR6HRH1CHRM2
SCHEMBL7467529 0.81 HTR6 (0.47) SCARB1HTR6HRH1CHRM2HTR1A
SCHEMBL13747590 0.80 L3MBTL1 (0.50) SCARB1KRASHTR6HRH1CHRM2
SCHEMBL4727325 0.80 MAPT (0.59) KRASHTR6HDAC1HDAC6MAPT
SCHEMBL4201950 0.79 SCARB1 (0.66) SCARB1
SCHEMBL4211410 0.78 SCARB1 (0.55) SCARB1HTR6
SCHEMBL4200388 0.77 SCARB1 (0.73) SCARB1
SCHEMBL4024931 0.76 SCARB1 (0.69) SCARB1HTR6HDAC1HDAC6KDM4E
SCHEMBL3857256 0.76 CA1 (0.65) HTR6HTR1AHTR2AHDAC1HDAC6
SCHEMBL1003815 0.75 HDAC1 (0.52) SCARB1KRASHDAC1HDAC6MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009103022-A1 DERIVATIVES OF SUBSTITUTED FUSED RING CYCLOINDOLES AND METHODS OF THEIR USE ITHERX PHARMACEUTICALS, INC. (US) 2009-08-20 WO disclosed